TAK-103
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for TAK-103, covering 2025-05-29 to 2026-07-07. Get the full timeline:
Most recent: Clinical Trial Results: A Study of TAK-103 in Adult With Solid Tumors [Phase 1]